| Authors: |
Yakushijin Y; Department of Clinical Oncology, Ehime University Graduate School of Medicine, Toon-City, Shitsukawa, Ehime, 7910295, Japan. yoshiyak@m.ehime-u.ac.jp.; Cancer Center, Ehime University Hospital, Toon-City, Ehime, Japan. yoshiyak@m.ehime-u.ac.jp., Horiba K; Pathogen Genomics Center, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-Ku, Tokyo, Japan., Hashino M; Pathogen Genomics Center, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-Ku, Tokyo, Japan., Yamanaka S; Cancer Center, Ehime University Hospital, Toon-City, Ehime, Japan., Hasebe S; Cancer Center, Ehime University Hospital, Toon-City, Ehime, Japan., Yamamoto S; Cancer Center, Ehime University Hospital, Toon-City, Ehime, Japan., Fujii T; Palliative Care Center, Ehime University Hospital, Toon-City, Ehime, Japan., Takenaka K; Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Toon-City, Ehime, Japan., Yasukawa M; Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Toon-City, Ehime, Japan. |